Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Wenliang Tan's publication output changed over time?
ScholarIQpublication output · 2017–2026
Output declined67% over the shown period — from 3 works in 2017 to 1 in 2026.
3
2
1
3
1
1
201720182019202220242026
What are the most-cited papers on Wenliang Tan?
ScholarIQmost cited works
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Wenliang Tan, Xuan Luo, Wenda Li, Jinyi Zhong, Jun Cao, Sicong Zhu, Xianqing Chen, Rui Zhou, Changzhen Shang, Yajin Chen
EBioMedicine. 2018110 CitationsOPEN ACCESS
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis
Rui Zhou, Dihan Lu, Wenda Li, Wenliang Tan, Sicong Zhu, Xianqing Chen, Jun Min, Changzhen Shang, Yajin Chen
HPB. 2019104 CitationsOPEN ACCESS
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
Chunxian Huang, Huaiwu Lu, Jing Li, Xiaofei Xie, Fan Li, Dongyan Wang, Wenliang Tan, Yaxian Wang, Zhongqiu Lin, Tingting Yao
Gynecologic Oncology. 201870 Citations
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang
Journal of Advanced Research. 202256 CitationsOPEN ACCESS
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang
S2754803477. 202453 CitationsOPEN ACCESS
Related on ScholarIQ
Central South University
Institution
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Paper
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis
Paper
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
Paper
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Paper
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
Paper